Marte C. Liefaard

492 citations
20 papers · 338 indexed · h-index 8
Topics
CAR-T cell therapy research (5 papers)HER2/EGFR in Cancer Research (5 papers)Cancer Genomics and Diagnostics (4 papers)

In The Last Decade

Marte C. Liefaard

19 papers receiving 334 citations

Peers

Marte C. Liefaard
Comparison fields: 5 of 68
  • Molecular Biology 190
  • Cancer Research 131
  • Oncology 87
  • Pathology and Forensic Medicine 58
  • Biomedical Engineering 46
Replace MAARET ESKELINEN with:
MAARET ESKELINEN Finland
He Zha China
Kristopher Koch United States
Gábor B. Brenner Hungary
Jianxin Wang China
Andi Zhao China
Barbara Siegele Germany
Richard P. Stevenson United Kingdom
Shunfang Liu China
Marte C. Liefaard relative to MAARET ESKELINEN Finland MAARET ESKELINEN's profile →
Citations per field
00.5×9.2×
MAARET ESKELINEN · 1×
Citations per year

Countries citing papers authored by Marte C. Liefaard

Since Specialization
Citations

This map shows the geographic impact of Marte C. Liefaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marte C. Liefaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marte C. Liefaard more than expected).

Fields of papers citing papers by Marte C. Liefaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marte C. Liefaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marte C. Liefaard. The network helps show where Marte C. Liefaard may publish in the future.

Co-authorship network of co-authors of Marte C. Liefaard

This figure shows the co-authorship network connecting the top 25 collaborators of Marte C. Liefaard. A scholar is included among the top collaborators of Marte C. Liefaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marte C. Liefaard. Marte C. Liefaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 0
3 1
4 1
5 10
6 1
7 1
8 14
9 11
10 3
11 5
12 3
13 7
14 1
15 1
16 1
17 24
18 173
19 7
20 70

About Marte C. Liefaard

Marte C. Liefaard is a scholar working on Oncology, Cancer Research and Immunology and Allergy, having authored 20 papers that have together received 338 indexed citations. Recurring topics across this work include CAR-T cell therapy research (5 papers), HER2/EGFR in Cancer Research (5 papers) and Cancer Genomics and Diagnostics (4 papers). The work is most often cited by research in Cancer Research (131 citations), Immunology and Allergy (27 citations) and Pathology and Forensic Medicine (58 citations). Marte C. Liefaard has collaborated with scholars based in Netherlands, Belgium and United States. Frequent co-authors include Esther H. Lips, Jelle Wesseling, Maarten Altelaar, Wei Wu, Jessica C. Kiefte–de Jong, Abbas Dehghan, Symen Ligthart, André G. Uitterlinden, Anna Vitezova and Albert Hofman. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026